The possible explanation for this derangements of lipid profile that observed in patients with PCOS might attributed to increase levels of androgens that associated with development of PCOS and this higher level of androgens result in impairment of insulin receptor sensitivity which leads to metabolic derangement with its atherogenic potential (32, 33). This evidence concerns the gene INSR and polycystic ovary syndrome.